Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Issue 3 (2023)

In vitro efficacy of systemic fungicides against Fusarium oxysporum f. sp. ciceri, causing chickpea wilt

Author(s):
Mergewar AR, Mulekar VG, Waghmare SV and Dudhe SP
Abstract:
Chickpea (Cicer arientum L.) is the most important pulse crop cultivated in India and affected by many fungal and viral diseases and among all the diseases, wilt caused by Fusarium oxysporum f. sp. ciceri is one of the most common fungal pathogen which causes ultimate yield loss in chickpea crop. Considering economic importance of the crop as well as destructive nature of the disease, present in vitro studies were undertaken to evaluate the efficacy of seven systemic fungicides (each @ 500 and 1000 ppm), to assess their potential against Fusarium oxysporum f. sp. ciceri. Results revealed that, mean mycelial growth inhibition of test pathogen recorded in all systemic fungicides ranged from 51.66% to 100% as compared with control (00.00%). The highest mycelial growth inhibition was resulted with Carbendazim 50% WP, Tebuconazole 25.9% EC and Thiophanate methyl 70% WP (100%), followed by Propiconazole 25% EC (91.11%), Difenconazole 25% EC (90.00%), Hexaconazole 5% EC (79.44%) and Fosetyl Al 80% WP (51.66%).
Pages: 5369-5372  |  189 Views  96 Downloads


The Pharma Innovation Journal
How to cite this article:
Mergewar AR, Mulekar VG, Waghmare SV, Dudhe SP. In vitro efficacy of systemic fungicides against Fusarium oxysporum f. sp. ciceri, causing chickpea wilt. Pharma Innovation 2023;12(3):5369-5372.

Call for book chapter